BioCentury
ARTICLE | Clinical News

XEN-D0501: Phase IIa started

July 21, 2014 7:00 AM UTC

Ario began a double-blind, placebo-controlled, crossover, U.K. Phase IIa trial to evaluate oral XEN-D0501 in about 20 patients with chronic idiopathic cough. XEN-D0501 is also in Phase IIa testing to ...